The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial

BACKGROUND/AIMS: DW1601, an oral fixed dose combination syrup composed of DW16011 and Pelargonium sidoides, was developed to enhance the symptom relief effect in patients with acute bronchitis. We evaluated the efficacy and safety of DW1601 compared to DW16011 or P. sidoides for treatment of acute b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young Seok, Lim, Seong Yong, Min, Kyung Hoon, Kim, Do Jin, Yoo, Kwang Ha, Kim, Tae-Bum, Kim, Hak-Ryul, Shim, Jae Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666245/
https://www.ncbi.nlm.nih.gov/pubmed/36153858
http://dx.doi.org/10.3904/kjim.2022.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666245/
https://www.ncbi.nlm.nih.gov/pubmed/36153858
http://dx.doi.org/10.3904/kjim.2022.104

Ejemplares similares